Peptide therapy involves administering specific peptides to target and modulate particular physiological functions
Duroux-Richard, I
Breaking that cycle requires accepting that plateaus are normal, temporary, and solvable with the right adjustments
This variation illustrates that the effects of GLP-1R stimulation can vary from individual to individual
Although SGLT-2 inhibitors and GLP-1 receptor agonists do not increase the risk of severe hypoglycemia, SGLT-2 inhibitors increase the risk of genital infections, and GLP-1 agonists have gastrointestinal adverse effects, especially at initiation and with high doses
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Herrera-Bravo J, Beltrn JF, Huard N, Saavedra K, Saavedra N, Alvear M, et al